ADAbhishek Dutta

Abhishek Dutta

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Abhishek Dutta has a total of 210 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Understanding the Application of Mechanical Dyssynchrony in Patients with Heart Failure Considered for CRT

    by Abhishek Dutta, Rakan Radwan M. Alqabbani, Andreas Hagendorff, Bhupendar Tayal

    Over the past two decades of CRT use, the failure rate has remained around 30–35%, despite several updates in the guidelines based on the understanding from multiple trials. This review article summarizes the role of mechanical dyssynchrony in the selection of heart failure patients for cardiac resynchronization therapy. Understanding the application of mechanical dyssynchrony has also evolved during these past two decades. There is no role of lone mechanical dyssynchrony in the patient selection for CRT. However, mechanical dyssynchrony can complement the electrocardiogram and clinical criteria and improve patient selection by reducing the failure rate. An oversimplified approach to mechanical dyssynchrony assessment, such as just estimating time-to-peak delays between segments, should not be used. Instead, methods that can identify the underlying pathophysiology of HF and are representative of a substrate to CRT should be applied.


  • Abstract 18887: Trends and Outcomes of Use of Inotropes in Cardiac Arrest Survivors With Ventriculartachycardia/Fibrillation

    by Abhishek Dutta, Krunalkumar Patel, Vien T Truong, Avilash Mondal, Mansoor Ahmad, Durgesh Agrawal, Tilachan Parajuli, Chaudry N Majeed, Thomas Metkus, Waqas Qureshi, et al.

  • Abstract 16558: Revascularization in Patients With Ischemic Cardiomyopathy and Viability: A Meta-Analysis of Randomized Controlled Trials

    by Vien T Truong, Tam Ngo, Hoang N Duong, Vivek Patel, Phan Q Dai, Mansoor Ahmad, Krunalkumar Patel, Abhishek Dutta, Amna Khan, Jay Jaiswal, et al.

  • Open Access

    TRANSIENT APICAL BALLOONING WITH NORMAL EJECTION FRACTION COMPLICATED BY LEFT VENTRICULAR THROMBUS

    by Mansoor Ahmad, Sunil Dhar, Thomas S. Metkus, Krunalkumar Patel, Vien Truong, Abhishek Dutta

  • Brain Natriuretic Peptide as a Marker of Adverse Neurological Outcomes Among Survivors of Cardiac Arrest

    by Abhishek Dutta, Zaid Alirhayim, Youssef Masmoudi, John Azizian, Lawson McDonald, Hanumantha R. Jogu, Waqas T. Qureshi, Nasir Majeed

    Neurological prognosis after cardiac arrest remains ill-defined. Plasma brain natriuretic peptide (BNP) may relate to poor neurological prognosis in brain-injury patients, though it has not been well studied in survivors of cardiac arrest. We performed a retrospective review and examined the association of BNP with mortality and neurological outcomes at discharge in a cohort of cardiac arrest survivors enrolled from January 2012 to December 2016 at the Wake Forest Baptist Hospital, in North Carolina. Cerebral performance category (CPC) and modified Rankin scales were calculated from the chart based on neurological evaluation performed at the time of discharge. The cohort was subdivided into quartiles based on their BNP levels after which multivariable adjusted logistic regression models were applied to assess for an association between BNP and poor neurological outcomes as defined by a CPC of 3 to 4 and a modified Rankin scale of 4 to 5. Of the 657 patients included in the study, 254 patients survived until discharge. Among these, poor neurological status was observed in 101 (39.8%) patients that had a CPC score of 3 to 4 and 97 patients (38.2%) that had a modified Rankin scale of 4 to 5. Mean BNP levels were higher in patients with poor neurological status compared to those with good neurological status at discharge (P = .03 for CPC 3-4 and P = .02 for modified Rankin score 4-5). BNP levels however, did not vary significantly between patients that survived and those that expired (P = .22). BNP did emerge as a significant discriminator between patients with severe neurological disability at discharge when compared to those without. The area under the curve for BNP predicting a modified Rankin score of 4 to 5 was 0.800 (95% confidence interval [CI] 0.756-0.844, P < .001) and for predicting CPC 3 to 4 was 0.797 (95% CI 0.756-0.838, P < .001). BNP was able to significantly improve the net reclassification index and integrated discriminatory increment (P < .05). BNP was not associated with long-term all-cause mortality (P > .05). In survivors of either inpatient or out-of-hospital cardiac arrest, increased BNP levels measured at the time of arrest predicted severe neurological disability at discharge. We did not observe an independent association between BNP levels and long-term all-cause mortality. BNP may be a useful biomarker for predicting adverse neurological outcomes in survivors of cardiac arrest.


  • PREVALENCE AND OUTCOMES OF GASTROINTESTINAL ANGIODYSPLASIA IN AORTIC STENOSIS PATIENTS: AN ANALYSIS OF NATIONAL READMISSION DATABASE

    by Yasar Sattar, Summer Aldrugh, Waseem Amjad, Lara Kovell, Abhishek Dutta, Abdul-Rahman M. Suleiman, Nikolaos Kakouros, M. Chadi Alraies, Waqas T. Qureshi


  • Characteristics and outcomes of cardiac arrest survivors with acute pulmonary embolism

    by Abhishek Dutta, Bhupendar Tayal, Kristian Hay Kragholm, Youssef Masmoudi, John Azizian, Lawson Mcdonald, Amandeep Goyal, Peter Sogaard, Waqas T. Qureshi


  • Incidence, Predictors, and Prognosis of Acute Kidney Injury Among Cardiac Arrest Survivors

    by Abhishek Dutta, Krupal J. Hari, John Azizian, Youssef Masmoudi, Fatima Khalid, Jamie L. Kowal, Muhammad Imtiaz Ahmad, Maryam Majeed, Lawson Macdonald, Padageshwar Sunkara, et al.

    Acute kidney injury (AKI) is common among cardiac arrest survivors. However, the outcomes and predictors are not well studied. This is a cohort study of cardiac arrest patients enrolled from January 2012 to December 2016 who were able to survive for 24 hours post-cardiopulmonary resuscitation. Patients with anuria, chronic kidney disease (stage 5), and end-stage renal disease were excluded. Acute kidney injury (stage 1) or higher was defined using Kidney Disease: Improving Global Outcomes classification. Multivariable adjusted regression models were used to compute hazard ratio (HR) for association of AKI with risk of mortality and odds ratio (OR) with risk of poor neurological outcomes after adjusting for demographics, comorbidities, and medical therapy. Multivariable logistic regression model was used to compute OR for association of various predictors with AKI. Of 842 cardiac arrest survivors, 588 (69.8%) developed AKI. Among AKI patients, 69.4% died compared with 52.0% among non-AKI patients. In multivariable adjusted Cox proportional hazard model, development of AKI post-cardiac arrest was significantly associated with mortality (HR: 1.35; 95% confidence interval [CI]: 1.07-1.71, P = .01) and poor neurological outcomes defined as cerebral performance category >2 (OR: 2.27; 95% CI: 1.45-3.57, P < .001) and modified Rankin scale >3 (OR: 2.22; 95% CI: 1.43-3.45, P < .001). Postdischarge dialysis was also associated with increased risk of mortality (HR: 2.57; 95% CI: 1.57-4.23, P < .001). Use of vasopressors was strongly associated with development of AKI and continued need for postdischarge dialysis. Acute kidney injury was associated with increased risk of mortality and poor neurological outcomes. There is need for further studies to prevent AKI in cardiac arrest survivors.


  • Open Access

    Wake Forest University long‐term follow‐up of type 2 myocardial infarction: The Wake‐Up T2MI Registry

    by Hanumantha R. Jogu, Sameer Arora, Muthiah Vaduganathan, Arman Qamar, Ambarish Pandey, Parag A. Chevli, Tusharkumar H. Pansuriya, Muhammad I. Ahmad, Abhishek Dutta, Padageshwar R. Sunkara, et al.

    Background The Wake‐Up T2MI registry is a retrospective cohort study investigating patients with Type 2 Myocardial Infarction (T2MI), acute myocardial injury, and chronic myocardial injury. We aim to explore risk stratification strategies and investigate clinical characteristics, management, and short‐ and long‐term outcomes in this high‐risk, understudied population. Methods From January 1, 2009, to December 31, 2010, 2,846 patients were identified with T2MI or myocardial injury defined as elevated cTnI with at least one value above the 99th percentile upper reference limit (URL) and coefficient of variation of 10% (>40 ng/L) and meeting our inclusion criteria. Data of at least two serial troponin values will be collected from the electronic health records to differentiate between acute and chronic myocardial injury. The Fourth Universal Definition will be used to classify patients as having (1) type 2 MI, (2) acute myocardial injury, or (3) chronic myocardial injury during the index hospitalization. Long‐term mortality data will be collected through data linkage with the National Death Index and North Carolina State Vital Statistics. Results We have collected data for a total of 2,205 patients as of November 2018. The mean age of the population was 65.6±16.9 years, 48% were men, and 64% were white. Common comorbidities included hypertension (71%), hyperlipidemia (35%), and diabetes mellitus (30%). At presentation, 40% were on aspirin, 38% on β‐blockers, and 30% on statins. Conclusion Improved characterization and profiling of this cohort may further efforts to identify evidence‐based strategies to improve cardiovascular outcomes among patients with T2MI and myocardial injury.


  • Contents

    by Calvin Ngai, Lisa Ganguzza, Laura Flink, Kathleen Woolf, Yu Guo, Victor Acosta, Eugenia Gianos, James Slater, Joseph Burdowski, Binita Shah, et al.